Reuters logo
BRIEF-Biogen, AbbVie get Health Canada approval of Zinbryta for MS
December 9, 2016 / 1:17 PM / a year ago

BRIEF-Biogen, AbbVie get Health Canada approval of Zinbryta for MS

Dec 9 (Reuters) - Biogen Inc :

* Biogen and AbbVie receive Health Canada approval of once-monthly Zinbryta (daclizumab beta) for multiple sclerosis

* Biogen Inc - Health Canada has approved Zinbryta for adult patients with active relapsing remitting multiple sclerosis Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below